ZTS:NYSE
Zoetis Inc
$79.56
arrow_upward
+0.23%(+0.18) 1D
Oct 19, 1:33:21 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$78.85
High
$79.71
Low
$78.45
Mkt. cap
32.88B
Avg. vol.
4.55M
Volume
1.11M
Dividend
2.66%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
13.09
52-wk high
$148.30
52-wk low
$68.77
EPS
$6.08
Beta
0.74
Shares outstanding
413.22M
No. of employees
14K
Open
$78.85
High
$79.71
Low
$78.45
Mkt. cap
32.88B
Avg. vol.
4.55M
Volume
1.11M
Dividend
2.66%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
13.09
52-wk high
$148.30
52-wk low
$68.77
EPS
$6.08
Beta
0.74
Shares outstanding
413.22M
No. of employees
14K
News stories
From web sources and news partners
Simply Wall Street
·
20 hours ago
Zoetis (ZTS) Could Be 15% Undervalued Following Its 2026 Earnings Outlook Cut
ad-hoc-news.de
·
1 day ago
Goldman Sachs starts coverage: Zoetis stock gets a USD 74 target
Simply Wall Street
·
1 day ago
Will Lower Earnings Outlook Change Zoetis Stock Narrative
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com